ProJenX

ProJenX is a clinical-stage biotechnology company developing novel, targeted brain penetrant therapies to address neurodegenerative diseases, with an initial focus on ALS. At the heart of ProJenXs approach is an innovative, patient-specific, cell-based drug discovery platform. Through a long-term research collaboration between Project ALS and resea... rchers at Columbia University, the company's team drove breakthroughs in stem cell biology and created the first ALS patient-derived disease models. These models drove insights into what goes wrong with motor neurons, the brain cells affected by ALS and how to rescue them.Read More